Xinhua Pharmaceutical
Xinhua Pharmaceutical, also known as SX Pharmaceutical, is a prominent player in the pharmaceutical industry, headquartered in the United States. Founded in 2003, the company has established a strong presence in major operational regions, focusing on the development and manufacturing of high-quality pharmaceutical products. Specialising in generic and specialty medications, Xinhua Pharmaceutical is recognised for its commitment to innovation and quality. The company’s core offerings include a diverse range of therapeutic solutions that cater to various medical needs, setting it apart in a competitive market. With a reputation for excellence, Xinhua Pharmaceutical has achieved significant milestones, positioning itself as a trusted name in the industry. Its dedication to research and development continues to drive its success, ensuring that it remains at the forefront of pharmaceutical advancements.
DitchCarbon Score
How does Xinhua Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Xinhua Pharmaceutical's score of 3 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Xinhua Pharmaceutical's reported carbon emissions
Xinhua Pharmaceutical, headquartered in the US, currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting its emissions. In the pharmaceutical industry, companies are increasingly recognising the importance of addressing climate change and reducing carbon footprints. As such, Xinhua Pharmaceutical may benefit from establishing clear emissions reduction targets and engaging in industry-standard climate initiatives to enhance its sustainability profile.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Xinhua Pharmaceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
